Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 826 results for "eli lilly"

Lilly, T1D Exchange ink diabetes research collaboration
Pharma Times

Lilly, T1D Exchange ink diabetes research collaboration

Eli Lilly has entered into a multi-year research collaboration with T1D Exchange, the first programme launched by US-based non-profit Unitio, to gather real-world insights into the experiences of people with . The collaboration will involve multiple ... Pharma Times, 1 day ago
[x]  

288 images for eli lilly

Live Trading News, 3 days ago
Zolmax News, 2 days ago
American Banking News, 4 days ago
Ulitzer, 4 days ago
American Banking News, 4 days ago
American Banking News, 4 days ago
Mideast Time, 4 days ago
4 Traders, 4 days ago
FOX 59, 1 week ago
Silicon Republic, 1 week ago
PRWeb

New York Law Firm Rudolph F.X. Migliore, P.C. Reports a U.S. Jury...

Takeda pharmaceutical company and marketing partner Eli Lilly have now been ordered by a Federal Court to pay for a Plaintiff's cancer injuries in connection with the drug Actos. A jury rewarded large punitive damages after they were instructed that ...
 PRWeb3 days ago Jury in southwest Louisiana federal court awards man $9 billion in bladder cancer case  The Southeast Texas Record3 days ago ELI LILLY : Fitch: Lilly's Ratings Intact Following $9B Actos Jury Verdict  4 Traders1 week ago Takeda, Lilly to Challenge $9 Billion Verdict in Diabetes Drug Case  PharmTech.com1 week ago
[x]  

Potential Eli Lilly (LLY) Trade Has 2.63% Downside Protection

After closing Tuesday at $59.42, Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY) presents an attractive opportunity to get a 3.70% return in just 66 days, which is an annualized return of 20.45% (for comparison purposes ...
 Individual.com2 days ago Potential Eli Lilly (LLY) Trade Targets 3.11% Return  Individual.com1 day ago Eli Lilly (LLY) Showing Resistance Near $59.32  Individual.com4 days ago
Asian Hospital & Healthcare Management

Lilly Confirms Date and Conference Call for First-Quarter 2014 Financial Results Announcement

/PRNewswire/ --Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2014 on Thursday, April 24 , 2014. Lilly will also conduct a conference call on that day with the investment community and media to further ...
 Asian Hospital & Healthcare Management3 days ago Lilly Schedules Conference Call for 1st Quarter 2014 Financial Results  Individual.com3 days ago ELI LILLY : Lilly Schedules Conference Call for 1st Quarter 2014 Financial Results  4 Traders3 days ago Eli Lilly and Company Confirms Date And Conference Call For First-Quarter 2014 Financial Results Announcement  BioSpace1 week ago
[x]  

Next Resistance Level for Eli Lilly (LLY) is $59.32

Shares of Eli Lilly (NYSE:LLY) opened today above their pivot of $58.46 and have already reached the first level of resistance at $58.88. Should the shares continue to rise, the resistance pivots of $59.32 and $60.18 will be
 Individual.com4 days ago Watch for Shares of Eli Lilly (LLY) to Approach Resistance at $59.70  Individual.com1 week ago

Global Depression Drugs Market 2014-2018 with GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Dominating

Research and Markets (http://www.researchandmarkets.com/research/gh6tqs/global_depression) has announced the addition of the "" report to their offering. Increasing public awareness regarding depression and associated disorders is expected to ...
 Individual.com4 days ago Research and Markets: Global Depression Drugs Market 2014-2018 with GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Dominating  TMC Net4 days ago RESEARCH AND MARKETS : Global Depression Drugs Market 2014-2018 with GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Dominating  4 Traders4 days ago Global Pain Management Drugs Market 2014-2018 with Abbott Labs, Eli Lilly, Endo Health Solutions, Pfizer & Purdue Pharma Dominating  Individual.com1 week ago
[x]  

Eli Lilly/ Boehringer Drug Under FDA Review

Eli Lilly and Company ( LLY ) and partner Boehringer Ingelheim Pharmaceuticals, Inc. announced that the new drug application (:NDA) for their empagliflozin−Tradjenta (linagliptin) combination has been accepted for review by the U.S. Food and Drug ...
 Yahoo! Finance3 days ago FDA spurns Lilly, Boehringer diabetes drug, cites factory problems  Reuters1 month ago
[x]  

BMO Capital Made the Right Call, Eli Lilly 0.6% Higher (LLY)

A week ago, BMO Capital upgraded Eli Lilly from Underperform to Market Perform. The shares closed at $58.95, or 0.6% over the $58.62 price of one
 Individual.com3 days ago
Seeking Alpha

Will Cymbalta Break Eli Lilly?

Summary Eli Lilly showed revenue growth over the past year of around 2 percent. Key revenue driver Cymbalta's patent expired in late 2013 giving way to further competition. A 3 billion dollar penalty was recently enforced because of damages over ...
 Seeking Alpha3 days ago

Eli Lilly's $3 Billion Mistake

After a long court battle for Eli Lilly ( NYSE: LLY ) and partner Takeda, alleging that the companies didn't adequately disclose the cancer risks for Takeda's drug Actos, a jury verdict from the Federal Court of Louisiana came back with a harsher ...
 Motley Fool4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less